The National Institutes of Health (NIH) has appointed Wendy Weber, a naturopathic physician, as the new director of the National Center for Complementary and Integrative Health (NCCIH), a move that has reignited debate about how federal research dollars are spent on alternative medicine. Weber, who began her role on August 23, 2026, will oversee approximately $170 million in annual research funding aimed at studying complementary and integrative health approaches.

The appointment marks a significant moment for NCCIH, which has long occupied a controversial position within the federal research landscape. The center funds investigations into treatments ranging from evidence-based lifestyle interventions like nutrition and exercise to more contested modalities such as acupuncture, herbal medicine, and other traditional practices. Weber's background as a licensed naturopathic physician, combined with her doctoral training in epidemiology, represents a deliberate choice to blend alternative medicine practice with scientific methodology.

What Is Naturopathy and How Does It Fit Into Federal Research?

Naturopathy traces its roots to the late 19th and early 20th centuries, when practitioners like Benedict Lust formulated the discipline by combining principles of natural healing with diverse health knowledge. The field emphasizes understanding how food, drink, occupation, and lifestyle factors affect individual health and constitution. However, the scope of what naturopathic practitioners study and recommend has historically extended well beyond evidence-based nutrition and exercise into territories that mainstream medicine views with skepticism.

Weber's appointment comes at a time when NCCIH's research priorities are under scrutiny. The center has historically funded studies on interventions that include:

• Botanical interventions: Clinical trials of plant-based treatments, including Echinacea for the common cold and St. John's Wort for attention-deficit/hyperactivity disorder
• Acupuncture research: Studies investigating acupuncture's mechanisms and effectiveness for chronic pain management
• Lifestyle and nutritional approaches: Research on diet, exercise, sleep, and other evidence-based health factors

Weber herself has conducted clinical trials of botanical interventions at Bastyr University and Massachusetts General Hospital. She was the first naturopathic physician to receive an NIH career development award, which supported her research into St. John's Wort for attention-deficit/hyperactivity disorder.

Why Does the Director's Background Matter for Research Funding?

The appointment of a naturopathic physician to lead NCCIH raises questions about how the center will prioritize research moving forward. Critics argue that lumping together evidence-based interventions like exercise and nutrition with less-proven modalities like acupuncture and herbal remedies can obscure which treatments actually work. This mixing of approaches, they contend, lends unwarranted credibility to alternative therapies by associating them with scientifically validated lifestyle changes.

NIH Director Jay Bhattacharya defended the appointment, stating that Weber's background in pain management research and whole-person health made her well-suited to lead the center. He emphasized that NCCIH's mission is to determine "the fundamental science, usefulness, and safety of complementary and integrative health approaches".

Weber's dual credentials in naturopathic medicine and doctoral-level epidemiology represent what supporters view as a bridge between alternative practice and rigorous scientific methodology. Her career has included both clinical investigations at academic medical centers and leadership in complementary health research.

How Does NCCIH Evaluate Research Quality?

The center's approach to evaluating complementary and integrative health approaches involves peer-reviewed clinical trials, systematic reviews, and mechanistic studies. However, the standards for what constitutes adequate evidence have been a point of contention. Previous NCCIH leadership pursued research aimed at identifying biological mechanisms for acupuncture, including attempts to correlate acupuncture "meridians" with anatomical structures using ultrasound and impedance measurements.

Weber's appointment signals a continuation of NCCIH's commitment to studying complementary approaches alongside conventional medical research. Her experience conducting clinical trials of botanical interventions and her track record of securing NIH funding suggest she will maintain the center's focus on rigorous investigation of alternative therapies.

The debate over NCCIH's role reflects broader questions about how federal research agencies should allocate resources. Supporters argue that investigating patient-preferred treatments and traditional medicine systems can yield valuable insights into health and disease. Critics contend that the center's existence and funding priorities implicitly validate unproven therapies by treating them as worthy of the same scientific scrutiny as evidence-based interventions.

As Weber assumes leadership of NCCIH, the center will continue managing research into complementary and integrative health approaches while navigating ongoing questions about scientific standards, research priorities, and the appropriate role of alternative medicine within the federal research enterprise.